Search Results
Results found for "Jana Selent"
- 📰 GPCR Weekly News, July 24 to July 30, 2023
Lukas Grätz, David Gloriam, and Gunnar Schulte’s research on Unveiling pathway selectivity in Frizzleds GPCR Activation and Signaling Endosome positioning coordinates spatially selective GPCR signaling. Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Higher specificity and reproducibility Well characterized ligands show consistent and selective binding Optimizing Fluorescence Channels and Fluorophore Selection for GPCR-Targeted Flow Cytometry The fluorophore
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Selective fluorescent CB1R ligands have been validated for flow cytometry [12], and selective CB2R probes To validate the potential of CELT-335 as a probe, seven reference compounds were selected. Table 2. The set of reference compounds were chosen to provide the highest diversification in affinity, selectivity 2017 , 376 (3), 235–242. https://doi.org/10.1056/NEJMoa1610300 . (10) Rosado, T.; Gonçalves ,Joana Protein Engineering Design and Selection 2006 , 19 (7), 309–316. https://doi.org/10.1093/protein/gzl014
- California gold rush for Sosei Heptares
Neurocrine Biosciences anticipates initiating a Phase 2 study with the selective M4 agonist HTL-0016878 in schizophrenia in 2022 and Phase 1 studies for a dual M1/M4 and selective M1 agonist in 2023."
- Fluorescence Polarization in GPCR Research
Using this method, binding affinity, kinetics and selectivity can all be measured and used to establish Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists. ACS Med Chem Lett. 2022 Jan 10;13(2):243-249. doi: 10.1021/acsmedchemlett.1c00598.
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
Naming what is deprioritized removes silent tension and reduces unnecessary expansion. 3️⃣ Treat strategic uncertainty does not quietly redirect the company without conscious choice. ✅ Biotech startups that avoid silent Founders who prevent silent failure do not wait for problems to surface. ✅ They continuously reinforce
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
Stimulation of AVPR2 with a selective agonist desmopressin promoted CRPC cell proliferation through cAMP In contrast, blocking AVPR2 with a selective FDA-approved antagonist, tolvaptan, reduced cell growth.
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
binding affinity experiments are interpreted—and how those interpretations quietly shape SAR, lead selection affinity experiments that tell the truth , ensuring affinity data support—rather than undermine—lead selection
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Adenine-derived scaffolds enabled selective adenosine receptor antagonists; tryptophan modifications This reroutes discovery toward: Functionally selective ligands Better therapeutic windows More predictable
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
receptor (GPCR) pharmacogenomics Miles D Thompson , David Reiner-Link , Alessandro Berghella , Brinda K Rana Ben Jones , Johannes Broichhagen Design of allosteric modulators that change GPCR G protein subtype selectivity which recognized native receptor Design of allosteric modulators that change GPCR G protein subtype selectivity domains of mammalian adenylyl cyclases are lipid receptors Structural insights into endogenous ligand selectivity
- Chemokine receptor-targeted drug discovery: progress and challenges
Proudfoot excluded the idea of molecular redundancy, pointing out that, in some cases, inappropriate target selection CKRs targeted drug discovery is the concept of biased agonism/antagonism, also known as functional selectivity Signaling bias can be seen as complex as advantageous since selectively inhibiting certain signaling
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
The mambaquaretin-1 (MQ1) peptide identified from the Dendroaspis angusticeps venom is the most selective The number of MQ1 residues involved in V2R binding is large and may explain its absolute selectivity.
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
This distinction is essential for designing drugs that selectively target these residues to achieve desired evolutionary standpoint, the study reveals that residues critical for β2AR function are under intense selective
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Activation and Signaling The ancestral ESCRT protein TOM1L2 selects ubiquitinated cargoes for retrieval Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells. Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Receptors
- Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures
structures is applied to explore the impact of binding of agonists and antagonist/inverse agonists to selected
- Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...
These effects are blocked by the selective small molecule GPR183 antagonist, SAE-14. the GPR183 agonist 7α,25-OHC induce behavioral hypersensitivity, and these effects are blocked by the selective
- Targeting the M1 muscarinic receptor in neurodegenerative disease
in cognitive and neurodegenerative disorders and the potential therapeutic benefit of muscarinic M1 selective
- Why Opposing Processes Matter for Your Next GPCR Drug
Ignore these forces, and your “selective” agonist may deliver surprises the first time it meets a patient This insight has huge implications for how you select and rank agonists in discovery campaigns.
- Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
a great number of bivalent ligands (i. e. aiming on two distinct OR subtypes), univalent heteromer-selective
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
generates a small pocket on the surface of MT1 receptor, which could participate in the recognition of MT1-selective ligands and may be exploited in the design of new selective compounds."
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
optimising physicochemical properties, understanding advanced molecular pharmacology such as functional selectivity
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
optimizing physicochemical properties, understanding advanced molecular pharmacology such as functional selectivity
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
In summary, a potent and selective APJ agonist suitable for in vivo studies of APJ in peripheral tissues
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
functional states have significantly improved our molecular understanding of CB1 ligand interactions, selectivity
- Dr. GPCR University registration is now open! Secure your spot now!
Decker, et al. for their study on Design, Synthesis, and Characterization of New δ Opioid Receptor-Selective Methods & Updates in GPCR Research Design, Synthesis, and Characterization of New δ Opioid Receptor-Selective
- 📰 GPCR Weekly News, June 24 to 30, 2024
Molecules Dates: September 5th to 26th, 2024 Course 2: Advanced Methods for the Optimization of Candidate Selection loop 3 in β2-adrenergic receptor Extensive location bias of the GPCR-dependent translatome via site-selective
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
The aim of this study was to test this hypothesis pharmacologically by using potent and selective Gq/
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
K., Selent, J., Hill, S. J., & Calebiro, D. (2023).
- Exscientia is 10 years old this July!
clinical trials, the first AI-driven precision medicine platform clinically validated to guide treatment selection
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
to treat idiopathic pulmonary fibrosis are currently ongoing using ligands with differing levels of selectivity












